Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)
- PMID: 35542995
- PMCID: PMC8920745
- DOI: 10.14283/jpad.2022.28
Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)
Conflict of interest statement
JS has no conflicts of interest to report. PMD has received grants, advisory fees, and/or stock from biotechnology companies and is a coinventor on patents for the diagnosis and treatment of dementia.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical